These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26942727)

  • 21. C-reactive protein and risk of venous thromboembolism in the general population.
    Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1672-8. PubMed ID: 20466978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
    Eichinger S; Heinze G; Jandeck LM; Kyrle PA
    Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study.
    Mollard LM; Le Mao R; Tromeur C; Le Moigne E; Gouillou M; Pan-Petesch B; Delluc A; Couturaud F; Lacut K
    Eur J Intern Med; 2018 Jun; 52():22-27. PubMed ID: 29548526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2016 Jul; 42(1):135-41. PubMed ID: 26743062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study.
    van Schouwenburg IM; Mahmoodi BK; Veeger NJ; Kluin-Nelemans HC; Gansevoort RT; Meijer K
    Br J Haematol; 2012 Mar; 156(5):667-71. PubMed ID: 22233096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating P-selectin and the risk of recurrent venous thromboembolism.
    Kyrle PA; Hron G; Eichinger S; Wagner O
    Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events.
    Chang WT; Chang CL; Ho CH; Hong CS; Wang JJ; Chen ZC
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28468786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors.
    Luong NV; Kroll MH; Vu K
    Thromb Res; 2017 Aug; 156():14-19. PubMed ID: 28577388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term recurrence risk after a first venous thromboembolism in men and women under 50 years old: A French prospective cohort.
    de Moreuil C; Le Mao R; Le Moigne E; Pan-Petesch B; Tromeur C; Hoffmann C; Salaun PY; Nonent M; Danguy des Déserts M; Savary X; Guegan M; Poulhazan E; Leroyer C; Lacut K; Couturaud F
    Eur J Intern Med; 2021 Feb; 84():24-31. PubMed ID: 33214024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
    Rodger MA; Le Gal G; Carrier M; Betancourt MT; Kahn SR; Wells PS; Anderson DA; Lacut K; Chagnon I; Solymoss S; Crowther M; Perrier A; White R; Vickars L; Ramsay T; Kovacs MJ
    Thromb Res; 2010 Sep; 126(3):222-6. PubMed ID: 20580413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.
    Gándara E; Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Solymoss S; Crowther M; Carrier M; Langlois N; Kovacs J; Little Ma J; Carson N; Ramsay T; Rodger MA
    Thromb Haemost; 2013 Dec; 110(6):1172-9. PubMed ID: 24067945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid lowering drugs and the risk of recurrent venous thromboembolism.
    Delluc A; Tromeur C; Le Moigne E; Nowak E; Mottier D; Le Gal G; Lacut K
    Thromb Res; 2012 Dec; 130(6):859-63. PubMed ID: 22939687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.
    Memon AA; Sundquist K; Wang X; Svensson PJ; Sundquist J; Zöller B
    J Thromb Thrombolysis; 2014 Oct; 38(3):348-54. PubMed ID: 24402195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.